Acequia Capital

"Complex financial models underpin all of the corporate world’s most important decisions. Until now, LLMs have barely touched this workflow. Tracelight is purpose-built for this; it works seamlessly inside the tools analysts already trust. Our aim is to take away the entire mechanical workload of financial modelling. Our users act as directors and orchestrators of AI that is quickly becoming superhuman at the task of Excel analysis."

"At ExpressionEdits, we’re revolutionizing gene expression by putting introns back where they belong, resulting in significant improvements in production"

"C the Signs is great for managing our cancer risk. I ran a middle-aged chap through the tool and followed the advice to order a chest x-ray and later sent a 2-week-wait referral to respiratory. It led to a lung cancer diagnosis, and he has since been operated on and doing well."

"our goal is to help developers in focusing all of their time and effort on creating incredible products and tools, without worrying about the quality of their code. This investment allows us to continue expanding the capabilities of what Sourcery can do, and help more developers around the world reach their full potential when coding"

"It is a huge achievement for us to be accepted onto Y Combinator and we’re incredibly excited to be a part of such a prestigious global movement that has an unparalleled track record for success. I know personally just how debilitating tinnitus can be and so as a team, we’re looking forward to learning from the very best innovators and entrepreneurs as we explore new ways to accelerate our growth and make a difference in the lives of as many people living with tinnitus as possible. Coupled with our pre-seed investment round, 2022 is shaping up to be a truly formidable year for Oto and for the tinnitus community."